Theratechnologies (THTX) Stock Highlights

1.2 | -12.41%

2024-09-19 06:24:45

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Statistics

Range Today

1.16 1.31

Volume Today 174K

Range 1 Year

0.88 2.58

Volume 1 Year 20.11M

Range 3 Year

0.88 17.84

Volume 3 Year 47.56M

Range 10 Year

0.88 45

Volume 10 Year 90.13M

Highlights

Market Capitalization 62.07M (small)

Floating Shares 34.24M

Current Price 1.2

Price To Earnings -9.62

Price To Revenue 1.03

Earnings Per Share -0.13

Payout Ratio 0%

Performance

Latest -12.41%

1 Month -12.41%

3 Months -4%

6 Months -3.23%

1 Year -49.79%

3 Years -91.67%

5 Years -92.87%

10 Years -42.31%

Benchmarks

Market Capitalization

43 / 54

Gross Profits

28 / 39

Total Revenue

36 / 50

Total Rank

50 / 54

Free Cashflow

25 / 54

Performance 5 years

47 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.